Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Goldman Sachs boosted the price target for Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) from $36 to $41. Goldman Sachs analyst Andrea Tan maintained a Neutral rating. Tarsus Pharmaceuticals shares closed at $46.65 on Thursday. See how other analysts view this stock.
- Deutsche Bank boosted the price target for The Walt Disney Company (NYSE:DIS) from $115 to $131. Deutsche Bank analyst Bryan Kraft maintained a Buy rating. Disney shares closed at $109.12 on Wednesday. See how other analysts view this stock.
- Needham raised Agilysys, Inc. (NASDAQ:AGYS) price target from $125 to $145. Needham analyst Mayank Tandon maintained a Buy rating. Agilysys shares settled at $120.84 on Wednesday. See how other analysts view this stock.
- Needham cut Applied Materials, Inc. (NASDAQ:AMAT) price target from $240 to $225. Needham analyst Charles Shi maintained a Buy rating. Applied Materials shares closed at $186.00 on Thursday. See how other analysts view this stock.
- Piper Sandler boosted Mastercard Incorporated (NYSE:MA) price target from $565 to $575. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. Mastercard shares closed at $520.40 on Thursday. See how other analysts view this stock.
- Benchmark boosted Tower Semiconductor Ltd. (NASDAQ:TSEM) price target from $55 to $60. Benchmark analyst Cody Acree maintained a Buy rating. Tower Semiconductor shares closed at $46.30 on Thursday. See how other analysts view this stock.
- Morgan Stanley cut the price target for SolarEdge Technologies, Inc. (NASDAQ:SEDG) from $23 to $9. Morgan Stanley analyst Andrew Percoco downgraded the stock from Equal-Weight to Underweight. SolarEdge shares settled at $12.83 on Thursday. See how other analysts view this stock.
- Baird boosted Biogen Inc. (NASDAQ:BIIB) price target from $294 to $300. Baird analyst Brian Skorney maintained an Outperform rating. Biogen shares closed at $164.89 on Thursday. See how other analysts view this stock.
- Baird raised the price target for Palo Alto Networks, Inc. (NASDAQ:PANW) from $385 to $425. Baird analyst Shrenik Kothari maintained an Outperform rating. Palo Alto shares closed at $394.39 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. cut Genelux Corporation (NASDAQ:GNLX) price target from $32 to $30. HC Wainwright & Co. analyst Emily Bodnar maintained a Buy rating. Genelux shares closed at $2.94 on Thursday. See how other analysts view this stock.
Considering buying DIS stock? Here’s what analysts think:
Read More: